Celldex Therapeutics (CLDX) Gross Margin (2010 - 2026)
Celldex Therapeutics' (CLDX) quarterly Gross Margin came in at 9620.0% in Q1 2026, down 940806.0% year-on-year from N/an in Q1 2025, and down 951.51% quarter-over-quarter from 914.88% in Q4 2025.
Celldex Therapeutics (CLDX) Gross Margin (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Gross Margin history runs 7 years deep, the most recent figure standing at 9620.0% for Q1 2026.
- On a quarterly basis, Gross Margin fell 940806.0% year-over-year to 9620.0% in Q1 2026; TTM through Mar 2026 was 510.51%, a 52490.0% decrease from a year earlier, with the FY2025 full-year figure at 288.16%, down 30823.0% from the prior year.
- Gross Margin fell to 9620.0% in Q1 2026 per CLDX's latest filing, from 914.88% in the prior quarter.
- Across five years, Gross Margin topped out at 66.34% in Q3 2024 and bottomed at 9620.0% in Q1 2026.
- The 3-year median for Gross Margin is 161.72% (2025), against an average of 1441.56%.
- Across the five-year window, Gross Margin soared 52652 bps in 2025 and tumbled 940806 bps in 2026, its largest moves.
- Year by year, Gross Margin stood at 37.36% in 2024, then sank by 2349 bps to 914.88% in 2025, then sank by 952 bps to 9620.0% in 2026.
- Per Business Quant, the three latest CLDX Gross Margin figures stand at 9620.0% (Q1 2026), 914.88% (Q4 2025), and 111.51% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn | -9,620.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,620.00% |
| Dec 31, 2025 | -914.88% |
| Jun 30, 2025 | -111.51% |
| Mar 31, 2025 | -211.94% |
| Dec 31, 2024 | -37.36% |
| Sep 30, 2024 | 66.34% |
| Jun 30, 2024 | 35.35% |
| Mar 31, 2024 | -738.46% |
| Dec 31, 2013 | 100.00% |
| Sep 30, 2013 | 100.00% |
| Jun 30, 2013 | 100.00% |
| Mar 31, 2013 | 3.31% |
| Dec 31, 2012 | 2.63% |
| Sep 30, 2012 | 3.44% |
| Jun 30, 2012 | 6.77% |
| Mar 31, 2012 | 3.66% |
| Dec 31, 2011 | 3.08% |
| Sep 30, 2011 | 1.90% |
| Jun 30, 2011 | 0.56% |
| Mar 31, 2011 | 0.56% |